Global cardiovascular disease risk score among U.S. adults with asthma

H. M. Lee, S. Truong, N. Wong (Irvine, United States Of America)

Source: Annual Congress 2010 - Comorbidity in obstructive airway disease
Session: Comorbidity in obstructive airway disease
Session type: Thematic Poster Session
Number: 2485
Disease area: Airway diseases

Congress or journal article abstract

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
H. M. Lee, S. Truong, N. Wong (Irvine, United States Of America). Global cardiovascular disease risk score among U.S. adults with asthma. Eur Respir J 2010; 36: Suppl. 54, 2485

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Global cardiovascular disease risk in U.S. adults by severity and presence of COPD
Source: Annual Congress 2010 - Comorbidity in obstructive airway disease
Year: 2010


Chronic asthma and the risk of cardiovascular disease
Source: Eur Respir Monogr 2020; 88: 82-95
Year: 2020


TENOR risk score predicts healthcare in adults with severe or difficult-to-treat asthma
Source: Eur Respir J 2006; 28: 1145-1155
Year: 2006



Obesity increases the risk of incident asthma among adults
Source: Eur Respir J 2005; 25: 282-288
Year: 2005



Prevalence of cardiovascular disease in COPD patients in the UK
Source: Annual Congress 2010 - Comorbidity in obstructive airway disease
Year: 2010

Management of patients with asthma or COPD and cardiovascular disease: risks versus benefits
Source: Eur Respir Monogr 2020; 88: 66-81
Year: 2020


Risk factors for severe asthma among adults with asthma
Source: Virtual Congress 2020 – Diagnosis and management of asthma
Year: 2020




Prevalence of COPD in the general population according to cardiovascular risk factors
Source: Eur Respir J 2007; 30: Suppl. 51, 778s
Year: 2007

Modifiable risk factors for all-cause hospitalization in obstructive lung disease
Source: International Congress 2015 – Risk factors and co-morbidities in asthma and COPD
Year: 2015

Assessment of 10-year risk for cardiovascular disease in patients with overlap syndrome
Source: International Congress 2018 – From continuous positive airway pressure (CPAP) and adherence to CPAP to asthma-COPD overlap syndrome (ACOS)
Year: 2018


Multi-symptom asthma as an indication of disease severity in epidemiology
Source: Eur Respir J 2011; 38: 825-832
Year: 2011



Exacerbations and mortality of COPD patients with cardiovascular disease in the UK
Source: Annual Congress 2010 - Comorbidity in obstructive airway disease
Year: 2010

Accelerated FEV1 decline and risk of cardiovascular disease and mortality in a primary care population of COPD patients
Source: Eur Respir J, 57 (3) 2000918; 10.1183/13993003.00918-2020
Year: 2021



Obesity in pediatric asthma: prevalence and impact on severity
Source: International Congress 2017 – Insight into childhood asthma and paediatric pulmonology
Year: 2017

Comorbidity: a distinctive feature of elderly respiratory patients
Source: Eur Respir Mon; 2009: 43: 205–216
Year: 2009

Early life risk factors for asthma outcomes in a cohort of young adults
Source: International Congress 2016 – Paediatric asthma: lessons learned from studies with large sample sizes and multi-centre drug studies
Year: 2016

Cumulative effect of smoking on disease burden and multimorbidity in adult-onset asthma
Source: Eur Respir J, 54 (3) 1801580; 10.1183/13993003.01580-2018
Year: 2019



Global and regional trends in mortality from chronic obstructive pulmonary disease: Their relation to poverty, smoking and population change
Source: International Congress 2014 – New insights into the epidemiology of COPD
Year: 2014

Risk factors for COPD mortality in women in the UK
Source: Eur Respir J 2006; 28: Suppl. 50, 463s
Year: 2006

Frequency of occurrence of risk factors of cardiovascular diseases and assessment of the total cardiovascular risk in patients with chronic obstructive pulmonary disease (COPD).
Source: International Congress 2019 – Multimorbidity in airway diseases and appropriate inhaled corticosteroid use in COPD
Year: 2019